Clinical Trial Update: Assess the Non-inferiority of GSK Biologicals' Mencevax™ ACWY (Manufactured by a New Process) vs Mencevax™ ACWY (the Already Existing Vaccine in the Market) When Given as a Single Dose to Subjects Aged 2-30 Yrs [Phase 4]

View source ↗

Summary

A Phase 4 trial assessed whether GSK's Mencevax ACWY manufactured via a new process is non-inferior to the existing vaccine when given as a single dose to indiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Infections

Drugs mentioned

• Mencevax ACWY

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Meningococcal | Phase 4 | Status: COMPLETED